USPTO serial 79255331
B
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 29, 2020
- Examiner
- NITKIN, DINISHA F
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with B?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zachary A. Aria
Zachary A. Aria Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Flasks for parenteral nutrition, namely, container and drug reconstitution system for injections and infusions, all being medical apparatus in the nature of infusion and injection devices for administering drugs; bottles for medical purposes all being for administering drugs sold empty, namely, bottles for oral injections, oral medicines, bottles for reagents, bottles for infusions, bottles for ophthalmic, optic or nasal applications, and oral tablet containers for dispensing medicine; dropper bottles for medical purposes for administering medication, sold empty; vaporizers for medical purposes; suction bottles for medical use, namely, feeding bottles, nursing bottles, dropper bottles for administering medication, sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges as medical devices; feeding bottles; droppers for medical purposes for administering medicine, sold empty; droppers for administering medication, sold empty; trays for holding surgical instruments; dispensers for administering medicine, namely, cups, spoons, dosing syringes, dosing devices in the nature of pill splitters for dispensing unit doses of medicine for medical purposes; measuring spoons for administering medicine; non-spill medicine spoons for administering medicine to infants; intravenous feeding bottles; medicinal bottle stoppers, namely, bottle stoppers specifically adapted for feeding bottles and baby bottles; breast milk storage bottles; medical tubing for administering drugs; injection devices for pharmaceuticals; dropping pipettes for medical purposes; containers made of glass or plastic for pharmaceutical or medical use for administering medicine, sold empty; bottles and flasks for disposal of medical instruments and other contaminated medical waste, namely, injections, medicinal products, reagents, infusions, aerosols, vials, ampoules, cartridges, syringes, pills; diagnostic devices, namely, preparation device for medical diagnostic uses, blood pressure and diabetic diagnostic medical devices, diagnostic kit consisting primarily of probes, buffers and reagents for use in microbial testing; plastic cartridges for diagnostic use, namely, blood sampling tubes; consumable cartridges for diagnostic use in laboratories, namely, blood sampling tubes; valves and accessories for the intravenous administration of medicinal products, namely, feeding bottle valves, intravenous bags sold empty, intravenous feeding tubes; feeding bottle stoppers, medical screw connectors and intravenous feeding tube extensions and intravenous feeding tube cannulas, intravenous feeding tube stopcock; medical diagnostic devices for sale in kits, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in microbial testing; clinical-medical test kits containing test pieces, analysis plates and indicator papers to assess the results of analyses being medical test kits for diabetes monitoring for home use, medical diagnostic apparatus for detecting cancer, diabetes; containers for medical reagents, namely, containers specially designed for transporting and holding radiopharmaceuticals; integrated electronic systems for the administration of medical substances comprised primarily of medical apparatus for intravenous administration of fluids in the nature of fluid warmers, spoons for administering medicine, intravenous feeding tubes and also containing computer hardware and software for administering medical substances; integrated electronic systems for the registration of medical data comprised primarily of medical devices used for the acquisition of physiological data for polysomnography, medical instruments for measuring and displaying medical data in the nature of blood pressures and lung capacity and also containing computer hardware and software for registering medical data; integrated electronic systems for the registration of pharmaceutical data comprised primarily of medical apparatus for introduction pharmaceutical preparations into the human body, medical instruments for measuring and displaying medical data in the nature of blood pressures and lung capacity, injection devices for pharmaceuticals and also containing computer hardware and software for registering pharmaceutical data; prostheses and medical implants consisting of artificial materials for surgical use; sterile containers for medical products, namely, containers for medical waste, blood containers for medical purposes sold empty; sterile surgical containers, namely, containers for medical waste, blood containers for medical purposes sold empty; plastic cartridges for containing and administering medical products for diagnostic use in laboratories for Point of Care Testing (POCT), namely, medical apparatus in the nature of infusion and injection devices for administering drugs; glass cartridges for containing and administering medical products for diagnostic use in laboratories for Point of Care Testing (POCT), namely, medical apparatus in the nature of infusion and injection devices for administering drugs; plastic cartridges for containing and administering reagents as parts of ultrasonic medical diagnostic apparatus; glass cartridges for containing and administering reagents as parts of ultrasonic medical diagnostic apparatus; metal needles for parenteral administration; drug recovery accessories, namely, drug delivery systems | ACTIVE | — |
| 020 | Plastic caps for containers; containers of plastic for pharmaceuticals, namely, plastic medication containers for commercial use; containers, not of metal, for transporting and holding pharmaceuticals; bottle closures, not of metal; caps for containers, not of metal or paper; containers of plastic for medication for commercial use; bottle tops in the nature of nonmetal screw tops, plastic caps; plastic tops for bottles in the nature of nonmetal screw tops, plastic caps, security tops; nonmetal screw tops and plastic capsules for the closing of containers; sealing caps, not of metal; plastic caps for tamper evident containers | ACTIVE | — |
| 021 | Cruets; cruet stands; glass bulb receptacles being containers for household use; flasks; plastic flasks; empty spray bottles; glass cartridges for medication, empty; pill boxes for personal use; pill boxes for personal use, not for medical purposes; personal dispensers for pills or capsules for domestic use; droppers sold empty for cosmetic purposes; bottles, sold empty; containers, namely, glass flasks; reusable plastic bottles, sold empty; anti-dripping devices for bottles, namely, drop collars to stops drips; glass stoppers for bottles; bottles for pharmaceuticals sold empty; apothecary jars of glass; dispensers for liquids for use with bottles namely, manually actuated pump dispensers for attachment to bottles for use in dispensing liquids | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bormioli Pharma S.p.a.
- Other trademarks owned by Bormioli Pharma S.p.a.
- Other trademarks owned by Bormioli Pharma S.p.a.
- Other trademarks in Class 010
- Other trademarks in Class 020
- Other trademarks in Class 021
- Similar marks named B
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 6, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 14, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 14, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 29, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 29, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 6, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 2, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 24, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 11, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 10, 2020 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jun 10, 2020 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Jun 10, 2020 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| May 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 24, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 24, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 24, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 1, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 1, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 1, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 18, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 2, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 2, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 10, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 2, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 28, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |